Complexa Inc. is a clinical stage biopharmaceutical company focused on transforming the lives of patients burdened with severe and life-threatening fibrosis and inflammatory diseases. The Company is developing medicines with the goal of preventing and repairing tissue injury and reversing fibrosis and inflammation. Our focus is on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart.